Cell Culture Media, Sera, and Reagents Market

Cell Culture Media, Sera, and Reagents Market (Product: Media, Sera, and Reagents; and End-user) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Cell Culture Media, Sera, and Reagents Market Outlook 2031

  • The global cell culture media, sera, and reagents market was valued at US$ 6.1 Bn in 2020
  • It is estimated to expand at a CAGR of 10.3% from 2021 to 2031
  • The global cell culture media, sera, and reagents market is expected to reach the value at US$ 18.3 Bn by the end of 2031

Analysts’ Viewpoint on Cell Culture Media, Sera, and Reagents Market Scenario

The global cell culture media, sera, and reagents market is majorly driven by growth and expansion of biotechnology & pharmaceutical companies and academic & research institutes. Ongoing research & development activities in biopharmaceuticals are expected to show profitable revenue opportunities for market players operating in the global cell culture media, sera, and reagents market. The increase in demand for biopharmaceuticals and artificial organs is also driving the expansion of the global market. Applications of biological drugs such as hormones, vaccines, antibodies, etc. are increasing due to the limited applicability of conventional pharmaceuticals for the treatment of various diseases.

Rise in Demand for Biopharmaceuticals to Drive Global Market

Cell culture products increase productivity by lowering manufacturing costs. Cell culture is a process of removing cells from an animal or plant source, and use these cells for creating biosimilar or biologic therapeutics. Due to the increasing demand for biosimilar and biologics products for the treatment of cancer and various other chronic and cardiovascular diseases, cell culture method is found to be effective and efficient in the biopharmaceutical sector.

Biosimilar products have gained tremendous popularity in North America and Europe. There is an increasing demand for cost-effective cell culture products and artificial organs across the globe. Antibiotics and amino acid supplements are the most common cell culture reagents used in developing nations. Moreover, increasing applications of Fetal bovine serum (FBS) in regulating cell membrane permeability is fueling the global market growth.

Stem Cell Research and Surge in Demand for Contract Manufacturing

Stem cell research is one of the key drivers for the global cell culture media, sera, and reagents market. Rise in awareness about the stem cell therapy for the treatment of various diseases is fueling market growth. Hence, there is an increasing demand for contract manufacturing. Rapid expansion of pharmaceutical companies, superior drug development & discovery procedures, increase in the number of clinical research institutes across the globe are some of the factors contributing to the global cell culture media, sera, and reagents market growth. However, high costs, along with the scarcity of suitable infrastructure for R&D is expected to hamper the market growth during the forecast period.

Lucrative Growth Opportunities in North America for Cell Culture Media, Sera, and Reagents Market Players

North America is expected to account for a major share of the global cell culture media, sera, and reagents market during the forecast period. The lucrative presence of market players operating in the North America cell culture media, sera, and reagents market is a major factor responsible for the market growth in the region. The North America cell culture media, sera, and reagents market is also driven by the strong support from governments, increasing investments in cell-based research & development, and regulatory approvals for cell culture-based vaccines.

The increase in demand for animal component-free media and automated cell culture systems is expected to create growth opportunities in North America for market players. In addition, the rising prevalence of diseases such as cancer in the region is contributing to the expansion of the market.

Countries in Asia Pacific such as China and India are the fastest growing markets for cell culture media, sera, and reagents in the region. Rapid urbanization and increasing investments in research activities are key factors contributing to the market growth in Asia Pacific. Companies operating in the regional market are expected to witness potential growth opportunities. Technological advancements in healthcare, high biopharmaceutical R&D expenditure, and greater adoption of advanced technologies are also fueling the growth of the market in the region.

Impact of COVID-19 on Cell Culture Media, Sera, and Reagents Market

The global coronavirus pandemic has created opportunities for manufacturers operating in the global cell culture media, sera, and reagents market. This is due to the increasing demand for vaccines across the globe. The global cell culture media, sera, and reagents market is expected to be driven by rising research-based activities, along with clinical trials of vaccines. The global cell culture media, sera, and reagents market is also fueled by surge in demand for biopharmaceuticals, increase in product development by key market contributors, and development of novel vaccines.

There is an increasing demand for cost-effective, reliable, low-risk, and highly efficient cell culture products such as bioreactors, media, reagents, and sera for the creation of high-yield cell lines. In order to fulfill this demand, many cell culture manufacturers are focusing on increasing the production of innovative products.

Cell Culture Media, Sera, and Reagents Market: Overview

  • A typical cell culture medium is composed of a complement of amino acids, vitamins, inorganic salts, glucose, and serum as a source of growth factors, hormones, and attachment factors
  • Cell culture reagents include cell culture media, media supplements, and sterile reagents. Common cell culture reagents are antibiotics and amino acid supplements.
  • The serum is a complex mix of albumins, growth factors, and growth inhibitors and is probably one of the most important components of a cell culture medium. Fetal bovine serum (FBS) is the most commonly used serum. The serum regulates cell membrane permeability and serves as a carrier for lipids, enzymes, micronutrients, and trace elements into the cell.

Rise in Demand for Biopharmaceuticals and Artificial Organs: Major Driver

  • The global biological drugs market, which is currently valued at over US$ 285.5 Bn, comprises hormones, vaccines, monoclonal antibodies, therapeutic enzymes, blood factors, etc. The limited applicability of conventional pharmaceuticals in curing diseased or injured tissues has led to an increase in demand for biologics.
  • The specificity of biopharmaceuticals has opened new avenues in health care such as personalized medicine, wherein various diseases or conditions can be treated using specific biomolecules depending upon the patient’s physiological, biological, and genetic makeup
  • Limited competition from generics (called biosimilars) is also driving the market, as these drugs are developed using unique processes involving growth of live cell cultures under controlled environmental conditions

Cell Culture Media, Sera, and Reagents Market: Segmentation

  • The global cell culture media, sera, and reagents market has been segmented based on product, end-user, and region
  • In terms of product, the global market has been classified into media, sera, and reagents. The media segment has been segregated into chemically defined, classical media, lysogeny broth, protein free, serum-free, and specialty media. The sera segment has been categorized into fetal bovine, newborn calf, and others. The reagents segment has been divided into albumin, amino acids, attached factors, and growth factors & cytokines.
  • Based on end-user, the global cell culture media, sera, and reagents market has been categorized into biotechnology & pharmaceutical companies, academic & research institutes, and others

North America to Dominate Cell Culture Media, Sera, and Reagents Market

  • In terms of region, the global cell culture media, sera, and reagents market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • North America is projected to dominate the global market from 2021 to 2031. The U.S. is the largest market for biopharmaceuticals, accounting for around a third of the global market, and is the world leader in biopharmaceutical R&D. According to the Pharmaceutical Research and Manufacturers Association (PhRMA), U.S. companies conduct over half the world's R&D. This drives the demand for cell culture media, sera, and reagents in North America.
  • Increase in demand for animal component-free media and automated cell culture systems are the key factors contributing to the growth of cell culture in North America. Additionally, recent reforms in the cell culture industry in the region regarding the use of human-derived media agents in cell culture are likely to fuel the growth of the market.

Major Players

  • Key players operating in the global cell culture media, sera, and reagents market include
    • Thermo Fisher Scientific, Inc.
    • Merck KGaA
    • Cytiva (Danaher Corporation)
    • Becton
    • Dickinson and Company
    • Corning Incorporated
    • HiMedia Laboratories
    • FUJIFILM Irvine Scientific, Inc.
    • InvivoGen
    • SeraCare (LGC Clinical Diagnostics, Inc.)
    • Lonza
  • Each of these players has been profiled in the cell culture media, sera, and reagents market report based on parameters such as company overview, financial overview, business strategies, application portfolio, business segments, and recent developments

Cell Culture Media, Sera, and Reagents Market Snapshot

Attribute

Detail

Market Size Value in 2020 (Base Year)

US$ 6.1 Bn

Market Forecast Value in 2031

US$ 18.3 Bn

Growth Rate (CAGR)

10.3%

Forecast Period

2021 to 2031

Quantitative Units

US$ Mn for Value

Market Analysis

It includes cross segment analysis at regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, pricing analysis, and parent industry overview.

Format

Electronic (PDF)

Market Segmentation

  • Product
    • Media
      • Chemically-defined
      • Classical Media
      • Lysogeny Broth
      • Protein Free
      • Serum-Free
      • Specialty Media
    • Sera
      • Fetal Bovine
      • Newborn Calf
      • Others
    • Reagents
      • Albumin
        • Human Serum Albumin
        • Bovine Serum Albumin
        • Recombinant Serum Albumin
        • Fetal Bovine
        • Newborn Calf
        • Others
      • Amino Acids
      • Attached Factors
      • Growth Factors & Cytokines
        • Transforming Growth Factor ß1
        • Epidermal Growth Factor
        • Interleukins & Interferons
        • Others
  • End-user
    • Biotechnology & Pharmaceutical Companies
    • Academic & Research Institutes
    • Others

Regions Covered

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Brazil
  • Mexico
  • Rest of Latin America
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Companies Profiled

  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • Cytiva (Danaher Corporation)
  • Becton, Dickinson and Company
  • Corning Incorporated
  • HiMedia Laboratories
  • FUJIFILM Irvine Scientific, Inc.
  • InvivoGen
  • SeraCare (LGC Clinical Diagnostics, Inc.)
  • Lonza

Customization Scope

Available upon request

Pricing

Available upon request

Frequently Asked Questions

What is the total market worth of cell culture media, sera, and reagents market?

Cell culture media, sera, and reagents market is expected to reach the value at US$ 18.3 Bn by the end of 2031

What is the anticipated CAGR of the cell culture media, sera, and reagents market in the forecast period?

Cell culture media, sera, and reagents market to expand at a CAGR of 10.3% from 2021 to 2031

What are the key driving factors for the growth of the cell culture media, sera, and reagents market?

Cell culture media, sera, and reagents market is driven by rise in demand for biopharmaceuticals

Which region is expected to project the highest market share in the global cell culture media, sera, and reagents market?

North America is expected to account for a major share of the global cell culture media, sera, and reagents market during the forecast period

Who are the key players in the cell culture media, sera, and reagents market?

Key players operating in the global cell culture media, sera, and reagents market include Thermo Fisher Scientific, Inc., Merck KGaA, Cytiva (Danaher Corporation), Becton, Dickinson and Company

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Cell Culture Media, Sera and Reagents Market

4. Market Overview

    4.1. Introduction

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Cell Culture Media, Sera and Reagents Market Analysis and Forecast, 2017–2031

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Key Industry Events

    5.2. COVID-19 Impact Analysis

6. Global Cell Culture Media, Sera and Reagents Market Analysis and Forecast, by Product

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Product, 2017–2031

        6.3.1. Media

            6.3.1.1. Chemically-defined

            6.3.1.2. Classical Media

            6.3.1.3. Lysogeny Broth

            6.3.1.4. Protein Free

            6.3.1.5. Serum Free

            6.3.1.6. Specialty Media

        6.3.2. Sera

            6.3.2.1. Fetal Bovine

            6.3.2.2. Newborn Calf

            6.3.2.3. Others

        6.3.3. Reagents

            6.3.3.1. Albumin

                6.3.3.1.1. Human Serum Albumin

                6.3.3.1.2. Bovine Serum Albumin

                6.3.3.1.3. Recombinant Serum Albumin

            6.3.3.2. Amino Acids

            6.3.3.3. Attached Factors

            6.3.3.4. Growth Factors & Cytokines

                6.3.3.4.1. Transforming Growth Factor ß1

                6.3.3.4.2. Epidermal Growth Factor

                6.3.3.4.3. Interleukins & Interferons

                6.3.3.4.4. Others

            6.3.3.5. Protease Inhibitors

            6.3.3.6. Thrombin

            6.3.3.7. Others

    6.4. Market Attractiveness Analysis, by Product

7. Global Cell Culture Media, Sera and Reagents Market Analysis and Forecast, by End-user

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by End-user, 2017–2031

        7.3.1. Biotechnology & Pharmaceutical Companies

        7.3.2. Academic & Research Institutes

        7.3.3. Others

    7.4. Market Attractiveness Analysis, by End-user

8. Global Cell Culture Media, Sera and Reagents Market Analysis and Forecast, by Region

    8.1. Key Findings

    8.2. Market Value Forecast, by Region

        8.2.1. North America

        8.2.2. Europe

        8.2.3. Asia Pacific

        8.2.4. Latin America

        8.2.5. Middle East & Africa

    8.3. Market Attractiveness Analysis, by Region

9. North America Cell Culture Media, Sera and Reagents Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

    9.2. Market Value Forecast, by Product, 2017–2031

        9.2.1. Media

            9.2.1.1. Chemically-defined

            9.2.1.2. Classical Media

            9.2.1.3. Lysogeny Broth

            9.2.1.4. Protein Free

            9.2.1.5. Serum Free

            9.2.1.6. Specialty Media

        9.2.2. Sera

            9.2.2.1. Fetal Bovine

            9.2.2.2. Newborn Calf

            9.2.2.3. Others

        9.2.3. Reagents

            9.2.3.1. Albumin

                9.2.3.1.1. Human Serum Albumin

                9.2.3.1.2. Bovine Serum Albumin

                9.2.3.1.3. Recombinant Serum Albumin

            9.2.3.2. Amino Acids

            9.2.3.3. Attached Factors

            9.2.3.4. Growth Factors & Cytokines

                9.2.3.4.1. Transforming Growth Factor ß1

                9.2.3.4.2. Epidermal Growth Factor

                9.2.3.4.3. Interleukins & Interferons

                9.2.3.4.4. Others

            9.2.3.5. Protease Inhibitors

            9.2.3.6. Thrombin

            9.2.3.7. Others

    9.3. Market Value Forecast, by End-user, 2017–2031

        9.3.1. Biotechnology & Pharmaceutical Companies

        9.3.2. Academic & Research Institutes

        9.3.3. Others

    9.4. Market Value Forecast, by Country, 2017–2031

        9.4.1. U.S.

        9.4.2. Canada

    9.5. Market Attractiveness Analysis

        9.5.1. By Product

        9.5.2. By End-user

        9.5.3. By Country

10. Europe Cell Culture Media, Sera and Reagents Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast, by Product, 2017–2031

        10.2.1. Media

            10.2.1.1. Chemically-defined

            10.2.1.2. Classical Media

            10.2.1.3. Lysogeny Broth

            10.2.1.4. Protein Free

            10.2.1.5. Serum Free

            10.2.1.6. Specialty Media

        10.2.2. Sera

            10.2.2.1. Fetal Bovine

            10.2.2.2. Newborn Calf

            10.2.2.3. Others

        10.2.3. Reagents

            10.2.3.1. Albumin

                10.2.3.1.1. Human Serum Albumin

                10.2.3.1.2. Bovine Serum Albumin

                10.2.3.1.3. Recombinant Serum Albumin

            10.2.3.2. Amino Acids

            10.2.3.3. Attached Factors

            10.2.3.4. Growth Factors & Cytokines

                10.2.3.4.1. Transforming Growth Factor ß1

                10.2.3.4.2. Epidermal Growth Factor

                10.2.3.4.3. Interleukins & Interferons

                10.2.3.4.4. Others

            10.2.3.5. Protease Inhibitors

            10.2.3.6. Thrombin

            10.2.3.7. Others

    10.3. Market Value Forecast, by End-user, 2017–2031

        10.3.1. Biotechnology & Pharmaceutical Companies

        10.3.2. Academic & Research Institutes

        10.3.3. Others

    10.4. Market Value Forecast, by Country/Sub-region, 2017–2031

        10.4.1. Germany

        10.4.2. U.K.

        10.4.3. France

        10.4.4. Italy

        10.4.5. Spain

        10.4.6. Rest of Europe

    10.5. Market Attractiveness Analysis

        10.5.1. By Product

        10.5.2. By End-user

        10.5.3. By Country/Sub-region

11. Asia Pacific Cell Culture Media, Sera and Reagents Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Product, 2017–2031

        11.2.1. Media

            11.2.1.1. Chemically-defined

            11.2.1.2. Classical Media

            11.2.1.3. Lysogeny Broth

            11.2.1.4. Protein Free

            11.2.1.5. Serum Free

            11.2.1.6. Specialty Media

        11.2.2. Sera

            11.2.2.1. Fetal Bovine

            11.2.2.2. Newborn Calf

            11.2.2.3. Others

        11.2.3. Reagents

            11.2.3.1. Albumin

                11.2.3.1.1. Human Serum Albumin

                11.2.3.1.2. Bovine Serum Albumin

                11.2.3.1.3. Recombinant Serum Albumin

            11.2.3.2. Amino Acids

            11.2.3.3. Attached Factors

            11.2.3.4. Growth Factors & Cytokines

                11.2.3.4.1. Transforming Growth Factor ß1

                11.2.3.4.2. Epidermal Growth Factor

                11.2.3.4.3. Interleukins & Interferons

                11.2.3.4.4. Others

            11.2.3.5. Protease Inhibitors

            11.2.3.6. Thrombin

            11.2.3.7. Others

    11.3. Market Value Forecast, by End-user, 2017–2031

        11.3.1. Biotechnology & Pharmaceutical Companies

        11.3.2. Academic & Research Institutes

        11.3.3. Others

    11.4. Market Value Forecast, by Country/Sub-region, 2017–2031

        11.4.1. Japan

        11.4.2. China

        11.4.3. India

        11.4.4. Australia & New Zealand

        11.4.5. Rest of APAC

    11.5. Market Attractiveness Analysis

        11.5.1. By Product

        11.5.2. By End-user

        11.5.3. By Country/Sub-region

12. Latin America Cell Culture Media, Sera and Reagents Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Product, 2017–2031

        12.2.1. Media

            12.2.1.1. Chemically-defined

            12.2.1.2. Classical Media

            12.2.1.3. Lysogeny Broth

            12.2.1.4. Protein Free

            12.2.1.5. Serum Free

            12.2.1.6. Specialty Media

        12.2.2. Sera

            12.2.2.1. Fetal Bovine

            12.2.2.2. Newborn Calf

            12.2.2.3. Others

        12.2.3. Reagents

            12.2.3.1. Albumin

                12.2.3.1.1. Human Serum Albumin

                12.2.3.1.2. Bovine Serum Albumin

                12.2.3.1.3. Recombinant Serum Albumin

            12.2.3.2. Amino Acids

            12.2.3.3. Attached Factors

            12.2.3.4. Growth Factors & Cytokines

                12.2.3.4.1. Transforming Growth Factor ß1

                12.2.3.4.2. Epidermal Growth Factor

                12.2.3.4.3. Interleukins & Interferons

                12.2.3.4.4. Others

            12.2.3.5. Protease Inhibitors

            12.2.3.6. Thrombin

            12.2.3.7. Others

    12.3. Market Value Forecast, by End-user, 2017–2031

        12.3.1. Biotechnology & Pharmaceutical Companies

        12.3.2. Academic & Research Institutes

        12.3.3. Others

    12.4. Market Value Forecast, by Country/Sub-region, 2017–2031

        12.4.1. Brazil

        12.4.2. Mexico

        12.4.3. Rest of LATAM

    12.5. Market Attractiveness Analysis

        12.5.1. By Product

        12.5.2. By End-user

        12.5.3. By Country/Sub-region

13. Middle East & Africa Cell Culture Media, Sera and Reagents Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Product, 2017–2031

        13.2.1. Media

            13.2.1.1. Chemically-defined

            13.2.1.2. Classical Media

            13.2.1.3. Lysogeny Broth

            13.2.1.4. Protein Free

            13.2.1.5. Serum Free

            13.2.1.6. Specialty Media

        13.2.2. Sera

            13.2.2.1. Fetal Bovine

            13.2.2.2. Newborn Calf

            13.2.2.3. Others

        13.2.3. Reagents

            13.2.3.1. Albumin

                13.2.3.1.1. Human Serum Albumin

                13.2.3.1.2. Bovine Serum Albumin

                13.2.3.1.3. Recombinant Serum Albumin

            13.2.3.2. Amino Acids

            13.2.3.3. Attached Factors

            13.2.3.4. Growth Factors & Cytokines

                13.2.3.4.1. Transforming Growth Factor ß1

                13.2.3.4.2. Epidermal Growth Factor

                13.2.3.4.3. Interleukins & Interferons

                13.2.3.4.4. Others

            13.2.3.5. Protease Inhibitors

            13.2.3.6. Thrombin

            13.2.3.7. Others

    13.3. Market Value Forecast, by End-user, 2017–2031

        13.3.1. Biotechnology & Pharmaceutical Companies

        13.3.2. Academic & Research Institutes

        13.3.3. Others

    13.4. Market Value Forecast, by Country/Sub-region, 2017–2031

        13.4.1. GCC Countries

        13.4.2. South Africa

        13.4.3. Rest of MEA

    13.5. Market Attractiveness Analysis

        13.5.1. By Product

        13.5.2. By End-user

        13.5.3. By Country/Sub-region

14. Competition Landscape

    14.1. Market Player - Competition Matrix (by tier and size of companies)

    14.2. Company Profiles

        14.2.1. Thermo Fisher Scientific, Inc.

            14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.1.2. Product Portfolio

            14.2.1.3. SWOT Analysis

            14.2.1.4. Strategic Overview

        14.2.2. Merck KGaA

            14.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.2.2. Product Portfolio

            14.2.2.3. SWOT Analysis

            14.2.2.4. Strategic Overview

        14.2.3. Cytiva (Danaher Corporation)

            14.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.3.2. Product Portfolio

            14.2.3.3. SWOT Analysis

            14.2.3.4. Strategic Overview

        14.2.4. Becton, Dickinson and Company

            14.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.4.2. Product Portfolio

            14.2.4.3. SWOT Analysis

            14.2.4.4. Strategic Overview

        14.2.5. Corning Incorporated

            14.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.5.2. Product Portfolio

            14.2.5.3. SWOT Analysis

            14.2.5.4. Strategic Overview

        14.2.6. HiMedia Laboratories

            14.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.6.2. Product Portfolio

            14.2.6.3. SWOT Analysis

            14.2.6.4. Strategic Overview

        14.2.7. FUJIFILM Irvine Scientific, Inc.

            14.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.7.2. Product Portfolio

            14.2.7.3. SWOT Analysis

            14.2.7.4. Strategic Overview

        14.2.8. InvivoGen

            14.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.8.2. Product Portfolio

            14.2.8.3. SWOT Analysis

            14.2.8.4. Strategic Overview

        14.2.9. SeraCare (LGC Clinical Diagnostics, Inc.)

            14.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.9.2. Product Portfolio

            14.2.9.3. SWOT Analysis

            14.2.9.4. Strategic Overview

        14.2.10. Lonza

            14.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.10.2. Product Portfolio

            14.2.10.3. SWOT Analysis

            14.2.10.4. Strategic Overview

List of Table

Table 01: Global Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Product, 2017–2031

Table 02: Global Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Media, 2017–2031

Table 03: Global Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Sera, 2017–2031

Table 04: Global Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Reagents, 2017–2031

Table 05: Global Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Albumin, 2017–2031

Table 06: Global Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Growth Factors & Cytokines, 2017–2031

Table 07: Global Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by End-user, 2017–2031

Table 08: Global Cell Culture Media, Sera and Reagents Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 09: North America Cell Culture Media, Sera and Reagents Market Analysis Value (US$ Mn) Forecast, by Country, 2017–2031

Table 10: North America Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Product, 2017–2031

Table 11: North America Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Media, 2017–2031

Table 12: North America Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Sera, 2017–2031

Table 13: North America Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Reagents, 2017–2031

Table 14: North America Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Albumin, 2017–2031

Table 15: North America Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Growth Factors & Cytokines, 2017–2031

Table 16: North America Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by End-user, 2017–2031

Table 17: Europe Cell Culture Market Analysis Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 18: Europe Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Product, 2017–2031

Table 19: Europe Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Media, 2017–2031

Table 20: Europe Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Sera, 2017–2031

Table 21: Europe Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Reagents, 2017–2031

Table 22: Europe Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Albumin, 2017–2031

Table 23: Europe Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Growth Factors & Cytokines, 2017–2031

Table 24: Europe Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by End-user, 2017–2031

Table 25: Asia Pacific Cell Culture Market Analysis Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 26: Asia Pacific Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Product, 2017–2031

Table 27: Asia Pacific Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Media, 2017–2031

Table 28: Asia Pacific Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Sera, 2017–2031

Table 29: Asia Pacific Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Reagents, 2017–2031

Table 30: Asia Pacific Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Albumin, 2017–2031

Table 31: Asia Pacific Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Growth Factors & Cytokines, 2017–2031

Table 32: Asia Pacific Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by End-user, 2017–2031

Table 33: Latin America Cell Culture Market Analysis Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 34: Latin America Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Product, 2017–2031

Table 35: Latin America Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Media, 2017–2031

Table 36: Latin America Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Sera, 2017–2031

Table 37: Latin America Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Reagents, 2017–2031

Table 38: Latin America Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Albumin, 2017–2031

Table 39: Latin America Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Growth Factors & Cytokines, 2017–2031

Table 40: Latin America Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by End-user, 2017–2031

Table 41: Middle East & Africa Cell Culture Market Analysis Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 42: Middle East & Africa Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Product, 2017–2031

Table 43: Middle East & Africa Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Media, 2017–2031

Table 44: Middle East & Africa Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Sera, 2017–2031

Table 45: Middle East & Africa Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Reagents, 2017–2031

Table 46: Middle East & Africa Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Albumin, 2017–2031

Table 47: Middle East & Africa Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Growth Factors & Cytokines, 2017–2031

Table 48: Middle East & Africa Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by End-user, 2017–2031

List of Figures

Figure 01: Global Cell Culture Media, Sera and Reagents Market Value (US$ Mn) Forecast, 2017–2031

Figure 02: Global Cell Culture Media, Sera and Reagents Market Value Share, by Region, 2020

Figure 03: Global Cell Culture Media, Sera and Reagents Market Attractiveness Analysis, by Product, 2021–2031

Figure 04: Global Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn), by Media, 2017–2031

Figure 05: Global Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn), by Sera, 2017–2031

Figure 06: Global Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn), by Sera, 2017–2031

Figure 07: Global Cell Culture Media, Sera and Reagents Market Attractiveness Analysis, by Product, 2021–2031

Figure 08: Global Cell Culture Media, Sera, and Reagents Market, by End-user, 2021–2031

Figure 09: Global Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn), by Biotechnology & Pharmaceutical Companies, 2017–2031

Figure 10: Global Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn), by Academic & Research Institutes, 2017–2031

Figure 11: Global Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn), by Others, 2017–2031

Figure 12: Global Cell Culture Media, Sera and Reagents Market Attractiveness Analysis, by End-user, 2021–2031

Figure 13: Global Cell Culture Media, Sera, and Reagents Market Value Share Analysis, by Region, 2020 and 2031 

Figure 14: Global Cell Culture Media, Sera and Reagents Market Attractiveness Analysis, by Region, 2021–2031

Figure 15: North America Cell Culture Media, Sera and Reagents Market Analysis Value (US$ Mn) Forecast, 2017–2031

Figure 16: North America Cell Culture Media, Sera and Reagents Market Analysis Value Share Analysis, by Country, 2020 and 2031

Figure 17: North America Cell Culture Media, Sera and Reagents Market Analysis Attractiveness Analysis, by Country 2021–2031

Figure 18: North America Cell Culture Media, Sera and Reagents Market Value Share Analysis, by Product, 2020 and 2031

Figure 19: North America Cell Culture Media, Sera and Reagents Market Attractiveness Analysis, by Product, 2021–2031

Figure 20: North America Cell Culture Media, Sera and Reagents Market Value Share Analysis, by End-user, 2020 and 2031

Figure 21: North America Cell Culture Media, Sera and Reagents Market Attractiveness Analysis, by End-user, 2021–2031

Figure 22: Europe Cell Culture Media, Sera and Reagents Market Analysis Value (US$ Mn) Forecast, 2017–2031

Figure 23: Europe Cell Culture Market Analysis Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 24: Europe Cell Culture Market Analysis Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 25: Europe Cell Culture Media, Sera and Reagents Market Value Share Analysis, by Product, 2020 and 2031

Figure 26: Europe Cell Culture Media, Sera and Reagents Market Attractiveness Analysis, by Product, 2021–2031

Figure 27: Europe Cell Culture Media, Sera and Reagents Market Value Share Analysis, by End-user, 2020 and 2031

Figure 28: Europe Cell Culture Media, Sera and Reagents Market Attractiveness Analysis, by End-user, 2021–2031

Figure 29: Asia Pacific Cell Culture Media, Sera and Reagents Market Analysis Value (US$ Mn) Forecast, 2017–2031

Figure 30: Asia Pacific Cell Culture Market Analysis Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 31: Asia Pacific Cell Culture Market Analysis Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 32: Asia Pacific Cell Culture Media, Sera and Reagents Market Value Share Analysis, by Product, 2020 and 2031

Figure 33: Asia Pacific Cell Culture Media, Sera and Reagents Market Attractiveness Analysis, by Product, 2021–2031

Figure 34: Asia Pacific Cell Culture Media, Sera and Reagents Market Value Share Analysis, by End-user, 2020 and 2031

Figure 35: Asia Pacific Cell Culture Media, Sera and Reagents Market Attractiveness Analysis, by End-user, 2021–2031

Figure 36: Latin America Cell Culture Media, Sera and Reagents Market Analysis Value (US$ Mn) Forecast, 2017–2031

Figure 37: Latin America Cell Culture Market Analysis Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 38: Latin America Cell Culture Market Analysis Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 39: Latin America Cell Culture Media, Sera and Reagents Market Value Share Analysis, by Product, 2020 and 2031

Figure 40: Latin America Cell Culture Media, Sera and Reagents Market Attractiveness Analysis, by Product, 2021–2031

Figure 41: Latin America Cell Culture Media, Sera and Reagents Market Value Share Analysis, by End-user, 2020 and 2031

Figure 42: Latin America Cell Culture Media, Sera and Reagents Market Attractiveness Analysis, by End-user, 2021–2031

Figure 43: Middle East & Africa Cell Culture Media, Sera and Reagents Market Analysis Value (US$ Mn) Forecast, 2017–2031

Figure 44: Middle East & Africa Cell Culture Market Analysis Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 45: Middle East & Africa Cell Culture Market Analysis Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 46: Middle East & Africa Cell Culture Media, Sera and Reagents Market Value Share Analysis, by Product, 2020 and 2031

Figure 47: Middle East & Africa Cell Culture Media, Sera and Reagents Market Attractiveness Analysis, by Product, 2021–2031

Figure 48: Middle East & Africa Cell Culture Media, Sera and Reagents Market Value Share Analysis, by End-user, 2020 and 2031

Figure 49: Middle East & Africa Cell Culture Media, Sera and Reagents Market Attractiveness Analysis, by End-user, 2021–2031

Copyright © Transparency Market Research, Inc. All Rights reserved